A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics.
Lee HM, Wright WC, Pan M, Low J, Currier D, Fang J, Singh S, Nance S, Delahunty I, Kim Y, Chapple RH, Zhang Y, Liu X, Steele JA, Qi J, Pruett-Miller SM, Easton J, Chen T, Yang J, Durbin AD, Geeleher P.
Lee HM, et al. Among authors: kim y.
Nat Commun. 2023 Nov 13;14(1):7332. doi: 10.1038/s41467-023-43134-0.
Nat Commun. 2023.
PMID: 37957169
Free PMC article.